Session » (2547–2566) ARP Posters I

Date: Tuesday, October 28, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 2564

An illustration-based patient-reported outcome measure reveals concealed symptoms in patients with rheumatoid arthritis and the factor contributing to the discrepancy between patient and evaluator global assessments

10:30AM-12:30PM: Abstract Number: 2565

Assessing Participation in the Lupus Sister Circle Support Group

10:30AM-12:30PM: Abstract Number: 2547

Assessing the Reach of a Virtual Education Program: Lupus & You: Answers. Advocacy. Action.

10:30AM-12:30PM: Abstract Number: 2550

Development of a ‘Training Toolkit’ to Support Advanced Practice Providers (APPs) Entry into a Rheumatology Musculoskeletal Ultrasound Subspecialty Clinic

10:30AM-12:30PM: Abstract Number: 2552

Effects of 360° Virtual Reality Embodiment Videos on Pain in Hand Osteoarthritis: A Within-Subject Pre-Post Study

10:30AM-12:30PM: Abstract Number: 2562

Enhancing Hand Osteoarthritis Classification with Generative AI: A CycleGAN and EfficientNetB7 Approach

10:30AM-12:30PM: Abstract Number: 2555

Ergonomic Modifications: Findings From the Making it WorkTM Systemic Sclerosis Program

10:30AM-12:30PM: Abstract Number: 2563

Factors Associated With Medication Use in the Preconception and Perinatal Period Among Women With Autoimmune Disorders: A Systematic Review

10:30AM-12:30PM: Abstract Number: 2553

Impact of Polypharmacy on Treatment Adherence and Its Effect on The Quality of Life in Patients with Rheumatic Diseases

10:30AM-12:30PM: Abstract Number: 2558

Impact of Social Determinants of Health on Patient Perceptions of Home Infusion Therapy in the Treatment of Rheumatologic Conditions

10:30AM-12:30PM: Abstract Number: 2559

Increasing Clinical Trial Awareness in Sample of Underrepresented Systemic Lupus Erythematosus Patients

10:30AM-12:30PM: Abstract Number: 2556

Information Needs of Patients with Vasculitis

10:30AM-12:30PM: Abstract Number: 2551

Integrating Advanced Practice Providers into a Rheumatology Musculoskeletal Ultrasound Clinic: Enhancing Patient Access and Procedural Expertise

10:30AM-12:30PM: Abstract Number: 2548

Management of Uncontrolled Gout Among Rheumatologists: Findings from a Medical Chart Audit

10:30AM-12:30PM: Abstract Number: 2561

Patient-Centricity: The Keystone to Recruitment and Retention of Research Participants for the Lupus Landmark Study and the Success of the Lupus Nexus

10:30AM-12:30PM: Abstract Number: 2549

Perceived Dignity in Patients With Rheumatic Disease

10:30AM-12:30PM: Abstract Number: 2560

Quality and Accuracy of TikTok Videos on Axial Spondyloarthritis: A Modified DISCERN Analysis

10:30AM-12:30PM: Abstract Number: 2554

Real-World Observations on Symptom Response and Tolerability of Intravenous Immunoglobulin in Patients with Inflammatory Myopathies through a Nurse-Led Outcomes Monitoring Program in a Home Infusion Setting

10:30AM-12:30PM: Abstract Number: 2557

Relationship Between Sleep Quality and Psychiatric Symptoms in Autoimmune Rheumatic Diseases

10:30AM-12:30PM: Abstract Number: 2566

Using Abdominal CT-Derived Bone Mineral Density and Psoas Volume for Opportunistic Osteoporosis Screening and Fracture Risk Assessment

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].